1 Interventional Pain Treatments in the Management of Oncologic Patients With Thoracic Spinal Tumor-Related Pain: A Case Series.

2 Effects of Catheter Tip Location on the Spread of Sensory Block Caused by a Continuous Thoracic Paravertebral Block: A Prospective, Randomized, Controlled, Double-Blind Study.

3 Unusual cutaneous metastatic carcinoma.

4 "The day you lose your hope is the day you start to die": Quality of life measured by young women with metastatic breast cancer.

5 What is a clinically meaningful survival benefit in refractory metastatic colorectal cancer?

6 targeted therapy for metastatic renal cell carcinoma

7 isolated asymptomatic masseter muscle metastasis as first sign of metastatic disease in a patient with known melanoma

8 breast cancer metastasis to the vulva 20 years remote from initial diagnosis: a case report and literature review

9 a near-complete response to treatment with gemcitabine plus nab®-paclitaxel in a patient with metastatic pancreatic cancer and poor performance status: a case report

10 squamous cell lung cancer presenting as a malar mass

11 metastatic cutaneous apocrine carcinoma: multidisciplinary approach achieving complete response with adjuvant chemoradiation

12 Direct correlation between MUC18 expression and metastatic potential of human melanoma cells

13 A Phase II trial of high dose epirubicin in patients with advanced breast carcinoma

14 Immunotherapy-based combinations in metastatic NSCLC

15 The effect of dose reduction of CDK4/6 inhibitors on survival in postmenopausal HR+ HER2-negative metastatic breast cancer.

16 Prediction of irinotecan toxicity in metastatic colorectal cancer patients based on machine learning models with pharmacokinetic parameters

17 Does Metastatic Lymph Node SUVmax Predict Survival in Patients with Esophageal Cancer?

18 Initial Experience of Pembrolizumab Therapy in Japanese Patients With Metastatic Urothelial Cancer.

19 Quantification of Economic Impact of Drug Wastage in Oral Oncology Medications: Comparison of 3 Methods Using Palbociclib and Ribociclib in Advanced or Metastatic Breast Cancer.

20 Afatinib for the treatment of metastatic non-small cell lung cancer

21 Afatinib for the treatment of metastatic non-small cell lung cancer

22 Afatinib for the treatment of metastatic non-small cell lung cancer

23 Severe Myositis, Myocarditis, and Myasthenia Gravis with Elevated Anti-Striated Muscle Antibody following Single Dose of Ipilimumab-Nivolumab Therapy in a Patient with Metastatic Melanoma

24 Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience

25 A Case Presentation of a Patient with Microsatellite Instability and BRAF Mutant Metastatic Colon Cancer and Bibliography Update

26 Multifocal Metastatic Breast Carcinoma to the Thyroid Gland Histologically Mimicking C Cell Lesions

27 Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy

28 Stauffer’s Syndrome in Patient with Metastatic Prostate Cancer

29 Metastatic colorectal cancer (mCRC): French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SFR).

30 Treatment of metastatic non-small cell lung cancer: 2018 guidelines of the Italian Association of Medical Oncology (AIOM).

31 A treatment landscape in evolution: new strategies, guidelines, and therapeutic advances for metastatic pancreatic adenocarcinoma

32 Utilization pattern and service settings of palliative care for patients with metastatic non-small-cell lung cancer.

33 [Metastatic bladder metachrone to a kaposi sarcoma cancer at a therapeutic impasse: about a case].

34 Retracted: Bisindole-oxadiazole hybrids, T3P mediated -synthesis and appraisal of their apoptotic, antimetastatic and computational Bcl-2 binding potential.

35 Essential Concepts for the Management of Metastatic Spine Disease: What the Surgeon Should Know and Practice.

36 Vinflunine in Metastatic Urothelial Carcinoma of the Bladder in Progression after a Platinum-Containing Regimen.

37 TUBB4B Downregulation Is Critical for Increasing Migration of Metastatic Colon Cancer Cells.

38 Correction to: Hysteresis control of epithelial-mesenchymal transition dynamics conveys a distinct program with enhanced metastatic ability (Nature Communications, (2018), 9, 1, (5005), 10.1038/s41467-018-07538-7)

39 Evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma of variant histology

40 Predicting Overall Survival in Patients with Metastatic Rectal Cancer: a Machine Learning Approach.

41 Can curcumin along with chemotherapeutic drug and lipid provide an effective treatment of metastatic colon cancer and alter multidrug resistance?

42 Challenges and Prospects of Chimeric Antigen Receptor T-cell Therapy for Metastatic Prostate Cancer.

43 Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment

44 Noninfectious causes of diffuse pulmonary infiltrations in chronic renal failure: metastatic pulmonary calsification.

45 Pilot study: use of gallium-68 PSMA PET for detection of metastatic lesions in patients with renal tumour.

46 Anti-metastatic effect of curcumin analog pentagamaboronon-0-fructose (PGB-0-F) against 4T1 breast cancer cells

47 Management of patients with metastatic prostate cancer (mPC) in a rural part of North Norway with a scattered population: does living near the department of oncology translate into a different pattern of care and survival?

48 Post-marketing observational study of everolimus in patients with unresectable or metastatic renal cell carcinoma in Japan.

49 Utilizing Molecular Network Information via Graph Convolutional Neural Networks to Predict Metastatic Event in Breast Cancer.

50 Screening and Stepped Care Targeting Psychological Distress in Patients With Metastatic Colorectal Cancer: The TES Cluster Randomized Trial.

51 Targeting prostate cancer cell proliferation, stemness and metastatic potential using derived phytochemicals.

52 Prevalence of BRAF gene mutation in samples of primary and metastatic colorectal cancer: A meta-analysis.

53 Impact of NCI Socioeconomic Index on the Outcomes of Nonmetastatic Breast Cancer Patients: Analysis of SEER Census Tract-Level Socioeconomic Database.

54 Dramatic response to Laetrile and cannabidiol (CBD)oil in a patient with metastatic low grade serous ovarian carcinoma

55 Tumor-to-Tumor Metastasis: Metastatic Invasive Lobular Carcinoma of the Breast within Adenocarcinoma of the Lung.

56 The PI3K/AKT/mTOR and CDK4/6 pathways in endocrine resistant HR+/HER2- metastatic breast cancer: Biological mechanisms and new treatments

57 Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.

58 Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline.

59 Outcome and feasibility of palliative chemotherapy in very elderly patients with metastatic breast cancer.

60 Greater Mindfulness Associated With Lower Pain, Fatigue, and Psychological Distress in Women with Metastatic Breast Cancer.

61 Brainwashed by extracellular vesicles: the role of extracellular vesicles in primary and metastatic brain tumour microenvironment

62 The clinical significance of metastatic breast carcinoma to intramammary lymph node.

63 Guideline Discordance and Patient Cost Responsibility in Medicare Beneficiaries With Metastatic Breast Cancer.

64 Bevacizumab Demonstrates Prolonged Disease Stabilization in Patients with Heavily Pretreated Metastatic Renal Cell Carcinoma: A Case Series and Review of the Literature

65 Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical Trial.

66 Synthesis, characterization, antimicrobial and antimetastatic activity of silver nanoparticles synthesized from Ficus ingens leaf

67 Poly(N,N-diethyl acrylamide)/functionalized graphene quantum dots hydrogels loaded with doxorubicin as a nano-drug carrier for metastatic lung cancer in mice

68 Metastatic pathway and the microvascular and physicochemical microenvironments of human melanoma xenografts.

69 CinéBreast-factors influencing the time to first metastatic recurrence in breast cancer: Analysis of real-life data from the French ESME MBC database.

70 CT-based radiomics for prediction of histologic subtype and metastatic disease in primary malignant lung neoplasms.

71 Aggressive End-of-Life Care for Metastatic Cancer Patients Younger Than Age 65 Years.

72 Metastatic potential and prognostic significance of SOX2: A meta-analysis.

73 Reply to “Letter to the Editor” intent of surgery of the primary tumor in metastatic breast cancer remains palliative

74 Complex management decisions in a woman with concurrent primary hyperparathyroidism and metastatic papillary thyroid carcinoma, both presenting during pregnancy.

75 Multifunctional polymeric micelle-based chemo-immunotherapy with immune checkpoint blockade for efficient treatment of orthotopic and metastatic breast cancer

76 Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer.

77 Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of Cisplatin Via Downregulation of Splenic CD44+, IL-17A+ MDSCs and Promotion of Circulating IFN-γ+ Myeloid Cells in the 4T1 Metastatic Breast Cancer Model.

78 Prospective, Multicenter Study of 5-Fluorouracil Therapeutic Drug Monitoring in Metastatic Colorectal Cancer Treated in Routine Clinical Practice.

79 The Metastatic Early Prognostic (MEP) score.

80 Does small volume metastatic lymph node disease affect long-term prognosis in early cervical cancer?

81 Asporin Restricts Mesenchymal Stromal Cell Differentiation, Alters the Tumor Microenvironment, and Drives Metastatic Progression.

82 Germline variants in asporin vary by race, modulate the tumor microenvironment, and are differentially associated with metastatic prostate cancer

83 Metastatic Metaphors: Poetry, Cancer Imagery, and the Imagined Self.

84 Metastatic or locally advanced breast cancer patients: towards an expert consensus on nab-paclitaxel treatment in HER2-negative tumours—the MACBETH project

85 Synchronicity of genetic variants between primary sites and metastatic lymph nodes, and prognostic impact in nodal metastatic lung adenocarcinoma

86 Trifluridine/Tipiracil for the Treatment of Metastatic Gastric Cancer.

87 [Clinical application of convolutional neural network in pathological diagnosis of metastatic lymph nodes of gastric cancer].

88 Recent advancements in the treatment of metastatic clear cell renal cell carcinoma: A review of the evidence using second-generation p-values.

89 Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent

90 The discordance pattern of molecular sub-types between primary and metastatic sites in Chinese breast cancer patients.

91 Magnetic iron oxide nanoparticles for imaging, targeting and treatment of primary and metastatic tumors of the brain.

92 A new 3D organotypic model of ovarian cancer to help evaluate the antimetastatic activity of RAPTA-C conjugated micelles.

93 Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets

94 Re: Safety and Outcomes of New Generation Hormone-Therapy in Elderly Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Patients in the Real World

95 Tumour-derived extracellular vesicles in blood of metastatic cancer patients associate with overall survival.

96 Relaxins enhance growth of spontaneous murine breast cancers as well as metastatic colonization of the brain.

97 "I'd Want to Know, Because a Year's Not a Long Time to Prepare for a Death": Role of Prognostic Information in Shared Decision Making among Women with Metastatic Breast Cancer.

98 Prognostic factors associated with locoronal relapses, metastatic relapses, and death among women with breast cancer. Population-based cohort study

99 PIK3CA mutations early persistence in cell-free tumor DNA as a negative prognostic factor in metastatic breast cancer patients treated with hormonal therapy

100 Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study.

101 Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer.

Keyword Connections

Journals

Research Groups

Bibliographies